Maternal –infant transmission of HIV-1

Laban Mtimavalye, Robert J. Biggar, Taha E. Taha, John Chiphangwi, Edward Connor, Rhoda Sperling, Richard D. Gelber, James Balsley

Research output: Contribution to journalLetter

Abstract

To the Editor: Connor et al. (Nov. 3 issue)1report that a multicenter clinical trial, conducted in the United States and France, demonstrated a reduction in maternal–infant transmission of the human immunodeficiency virus type 1 (HIV-1) with zidovudine treatment. Planning is now under way for studies of perinatal zidovudine in several African, Asian, and South American countries. In an ideal world, implementing zidovudine regimens to reduce maternal–infant HIV transmission in developing nations would be humane and appropriate. But in the real world, is this approach practical? Women in rural Africa often have little or no prenatal care, and identifying HIV-infected. . .

Original languageEnglish (US)
Pages (from-to)890-891
Number of pages2
JournalNew England Journal of Medicine
Volume332
Issue number13
DOIs
StatePublished - Mar 30 1995

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Maternal –infant transmission of HIV-1'. Together they form a unique fingerprint.

  • Cite this

    Mtimavalye, L., Biggar, R. J., Taha, T. E., Chiphangwi, J., Connor, E., Sperling, R., Gelber, R. D., & Balsley, J. (1995). Maternal –infant transmission of HIV-1. New England Journal of Medicine, 332(13), 890-891. https://doi.org/10.1056/NEJM199503303321313